MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$12,864M
(25.99%↑ Y/Y)
Non Us
$7,210M
(10.28%↑ Y/Y)
Net sales
$20,074M
(19.87%↑ Y/Y)
Gross profit
$13,854M
(20.57%↑ Y/Y)
Cost of products sold
(excluding amortization...
$6,221M
(18.34%↑ Y/Y)
Operating income (loss)
$3,613M
(38.80%↑ Y/Y)
Other, net
$121M
(856.25%↑ Y/Y)
Operating expenses
$10,241M
(15.24%↑ Y/Y)
Income (loss) before
income taxes
$3,385M
(48.33%↑ Y/Y)
Interest expense
$349M
(14.43%↑ Y/Y)
Selling, general and
administrative expenses
$6,887M
(15.09%↑ Y/Y)
Research and development
expenses
$2,052M
(27.06%↑ Y/Y)
Amortization expense
$897M
(4.79%↑ Y/Y)
Litigation-related net charges
(credits)
$194M
Restructuring net charges
(credits)
$101M
(531.25%↑ Y/Y)
Intangible asset
impairment charges
$46M
(-88.08%↓ Y/Y)
Royalty expense
$46M
(39.39%↑ Y/Y)
Contingent consideration
net expense...
$18M
(460.00%↑ Y/Y)
Net income (loss)
$2,892M
(56.66%↑ Y/Y)
Net income (loss)
attributable to...
-$6M
(25.00%↑ Y/Y)
Income tax expense
(benefit)
$493M
(13.07%↑ Y/Y)
Net income (loss)
attributable to boston...
$2,898M
(56.40%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
safari-pinned-tab-svg
BOSTON SCIENTIFIC CORP (BSX)
safari-pinned-tab-svg
BOSTON SCIENTIFIC CORP (BSX)